Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Please join us for the next iCMLf conversation on CML:

Update on pediatric CML: Treatment-free remission in children with CML

  • Professor Fréderic Millot, University of Poitiers (France)

Date: Tuesday, April 27, 2021 at 13.00 Central European Time (CET)

How can I dial into the webinar?
Please join this meeting from your computer, tablet or smartphone via the link:
https://us02web.zoom.us/j/81787321991
Meeting-ID: 817 8732 1991


iCMLf Conversations on CML - View expert discussions on CML management

CD5038 Conversations tile 27x128 

The iCMLf is hosting monthly 'iCMLf Conversations on CML' with expert live discussions on various topics in CML management. On this page you will find recordings from past conversations with renowned CML experts that cover a wide range of topics like;

  • Virtual iCMLf Forum: Meet-the-expert Session
  • CML highlights from ASH 2020
  • Treatment-free remission
  • Current research in CML
  • 2020 ELN recommendations

Watch out for more expert discussions in the next couple of weeks.

 

 

Virtual iCMLf Forum: Meet-the-expert Q&A Session

 

 


 

Collage Virtual Forum

 


 

 

  

Meet-the-expert Q&A Session

During the Q&A Session various questions on CML management were discussed like; treatment-free-remission, CML and JaK2 mutations, CML and evolution of MDS and CML and COVID-19.

Host: Nicola Evans (iCMLf)

 

For more information on global programs for patients with CML please contact
The MAX Foundation

 

  

Panel of experts:

  • Professor Jerry Radich
    Fred Hutchinson Cancer Research Center, Seattle (USA)
  • Professor Jane Apperley
    Imperial College London (UK)
  • Pat Garcia-Gonzalez
    CEO, The MAX Foundation, Seattle (USA)
  
       

Conversation on CML: CML Highlights from ASH 2020

    Collage ASH highlights 

 		  

Program:
Biological overview: (Susan Branford)

  • Single cell roadmap of immune cell response
    (ASH 2020: Huuhtanen J)
  • Prognostic relevance of genetic abnormalities in blast crisis
    (ASH 2020: Yotaro O)

Clinical Overview (Susanne Saussele)

  • ASCEMBL study (ASH 2020: Hochhaus et al)
  • OPTIC study (ASH 2020: Cortes et al)
  • JALSG Study (ASH 2020: Matsumara et al)
  • CANDID Study (ASH 2020: Rea et al)                                                                                                                 

Panel of experts:

  • Chairman: Professor Giuseppe Saglio
  • Professor Susan Branford
    SA Pathology / University of South Australia (Australia)
  • Professor Susanne Saussele
    University of Mannheim (Germany)

 

 

 

  
     

Conversation on CML: Update on Treatment Free Remission

 

Collage TimGiora



 

  

Program:
Update on TFR: (Timothy Hughes)

  • ELN/NCCN recommendations for TFR
  • Early BCR-ABL1 kinetics predictive for TFR
  • Probability of sustained TFR based on halving time
  • Precision medicine approach in CML: bioassay-directed management
  • Common questions regarding TFR

Global patients' survey on TFR (Giora Sharf)

  • The TFR4CML patients' research
  • Where is TFR done globally?
  • The phases of TFR
  • Results from the global survey: reasons for stopping treatment, topics discussed with doctors, doctor support, withdrawal syndrom, psychological support, information gaps
  

Panel of experts:

  • Professor Timothy Hughes
    SAHMRI/University of Adelaide (Australia)
  • Giora Sharf
    Co-Founder of CML Advocates Network / CML patient (Israel)